We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.3B
AUM Growth
+$229M
Cap. Flow
-$342M
Cap. Flow %
-2.78%
Top 10 Hldgs %
11.52%
Holding
627
New
166
Increased
116
Reduced
155
Closed
161

Sector Composition

Rank Sector Weight
1 Technology 14.15%
2 Healthcare 12.62%
3 Financials 12.54%
4 Industrials 12.05%
5 Consumer Discretionary 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
51
UnitedHealth
UNH
$369B
$69.1M 0.56%
421,520
+196,913
+88% +$32.2M
TSRO
52
DELISTED
TESARO, Inc.
TSRO
$69M 0.56%
448,373
+179,027
+66% +$29.1M
CRL icon
53
Charles River Laboratories
CRL
$12.4B
$67.1M 0.55%
746,476
-99,848
-12% -$8.48M
ARRS
54
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$67.1M 0.54%
+2,535,239
New +$70.9M
ASAP
55
CALL
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$65.5M 0.53%
50,000
PCRX icon
56
Pacira BioSciences
PCRX
$1.01B
$64.4M 0.52%
1,413,193
+870,083
+160% +$37.6M
VAL
57
DELISTED
Valspar
VAL
$61.9M 0.5%
+557,868
New +$61.2M
AMP icon
58
Ameriprise Financial
AMP
$49.1B
$61.8M 0.5%
+476,387
New +$59M
DNB
59
DELISTED
Dun & Bradstreet
DNB
$61.8M 0.5%
+572,091
New +$64.8M
NFX
60
DELISTED
Newfield Exploration
NFX
$61.6M 0.5%
1,669,986
-125,924
-7% -$4.9M
BMRN icon
61
BioMarin Pharmaceuticals
BMRN
$11.5B
$61.3M 0.5%
698,157
-174,544
-20% -$15.5M
TREE icon
62
LendingTree
TREE
$468M
$60.5M 0.49%
482,453
+219,134
+83% +$25M
NTB icon
63
Bank of N.T. Butterfield & Son
NTB
$2.43B
$59.5M 0.48%
1,866,039
+411,222
+28% +$13.4M
PVTB
64
DELISTED
PrivateBancorp Inc
PVTB
$59.4M 0.48%
+1,000,000
New +$56M
SM icon
65
SM Energy
SM
$7.02B
$59.3M 0.48%
+2,467,692
New +$68.4M
ELV icon
66
Elevance Health
ELV
$84.3B
$58.3M 0.47%
352,501
+329,735
+1,448% +$52.5M
ETFC
67
DELISTED
E*Trade Financial Corporation
ETFC
$58.1M 0.47%
+1,666,513
New +$59.8M
NOK icon
68
Nokia
NOK
$52.9B
$57.9M 0.47%
10,684,215
-365,775
-3% -$1.84M
WFM
69
DELISTED
Whole Foods Market Inc
WFM
$57.4M 0.47%
1,932,902
-1,145,033
-37% -$34.5M
WP
70
DELISTED
Worldpay, Inc.
WP
$57.2M 0.46%
891,370
-277,372
-24% -$17.6M
XOG
71
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$57.2M 0.46%
3,080,996
+2,254,776
+273% +$40.5M
PRAH
72
DELISTED
PRA Health Sciences, Inc.
PRAH
$57M 0.46%
874,281
+191,196
+28% +$11.3M
MON
73
DELISTED
Monsanto Co
MON
$56.6M 0.46%
+500,000
New +$55.3M
AMC icon
74
AMC Entertainment Holdings
AMC
$2.35B
$56.5M 0.46%
+179,663
New +$57.4M
EVHC
75
DELISTED
Envision Healthcare Holdings Inc
EVHC
$56.1M 0.46%
+915,450
New +$61.4M

Similar funds

Alyeska Investment Group's Q1 2017 Portfolio in Review

As of Q1 2017, Alyeska Investment Group held 627 positions worth $12.3B, up 1.9% from $12.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group's Q1 2017 filing shows 166 new, 116 increased, 155 reduced and 161 closed positions. Its largest new stake was Agilent Technologies: 2,378,330 shares worth $126M. The largest sale was Cisco, an estimated $141M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Alyeska Investment Group's largest Q1 2017 buy was Agilent Technologies: 2,378,330 shares worth $126M.
  • Alyeska Investment Group added most to Palo Alto Networks in Q1 2017, an estimated $167M increase.
  • Alyeska Investment Group's biggest Q1 2017 reduction was Cisco, cutting an estimated $141M.
  • Alyeska Investment Group fully exited Stryker in Q1 2017, selling an estimated $134M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $12.3B portfolio in Q1 2017.
  • Alyeska Investment Group opened 166 new positions and closed 161 in Q1 2017.
  • Alyeska Investment Group's portfolio value rose 1.9% quarter-over-quarter to $12.3B.

Based on Alyeska Investment Group's 13F filing for Q1 2017, filed 15 May 2017.